EyeSense Attracts QIAGEN As Strategic Investor

EyeSense Attracts QIAGEN As Strategic Investor

BASEL, Switzerland, January 11, 2011 /PRNewswire/ -- EyeSense AG, a leading developer of novel ophthalmic self-diagnostic systems for glucose monitoring of diabetes patients, today announced that it…